MTHFR Genetics UK (Lab)

mthfr-genetics.co.uk

We are all about empowering you, in knowledge about your body's biochemistry. Right down to the level of your genetics, and encouraging you to take a proactive approach to improving your health. This can be accomplished by applying lifestyle changes and reducing exposure to environmental factors, that may contribute to, or cause your genetic mutations to start expressing, causing a decline in your health as a result.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PROVENTION BIO AND VACTECH ANNOUNCE PUBLICATION OF PROOF-OF-CONCEPT DATA FOR COXSACKIEVIRUS B VACCINE

Provention Bio, Inc. | May 19, 2020

news image

The preclinical prototype vaccine is well-tolerated and provides strong protection against coxsackievirus B infections and diabetes in relevant animal models. Results provide a solid scientific basis for human trials with Provention's PRV-101 vaccine. Read More

Diagnostics

OXFORD BIOTHERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH IMMUNOGEN TO DEVELOP NOVEL ANTIBODY-DRUG CONJUGATES

Oxford BioTherapeutics | June 14, 2022

news image

Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced a multi-year collaboration to research, develop and commercialize novel, first-in-class ADCs with ImmunoGen (IMGN), a leader in the expanding field of ADCs for the treatment of cancer. The companies will utilize ImmunoGen's linker-payload technology directed to novel targets identified via OBT's proprietary OGAP® discove...

Read More

Industrial Impact

ADM FURTHER EXPANDS MICROBIAL SCIENCE AND TECHNOLOGY INNOVATION CAPABILITIES WITH INVESTMENT IN PRECISION FERMENTATION LEADER ACIES BIO

ADM | October 22, 2021

news image

ADM a global leader in nutrition and agricultural origination and processing, annoThis investment will help ADM more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio’s extensive microbial capabilities and contract manufacturing services. “Microbial technology is unlocking disruptive opportunities in sustainable agriculture, sustainable materials and fuels, and alternative proteins, We’re prope...

Read More

Cell and Gene Therapy, Medical

BE THE MATCH BIOTHERAPIES® INTRODUCES CIBMTR® CRO SERVICES

Be The Match BioTherapies® | January 18, 2023

news image

On January 17, 2023, Be The Match BioTherapies, a company that provides solutions for organizations that develop and commercialize cell and gene therapies, introduced its offering of CIBMTR® clinical research organization services (CRO services), which significantly reduces the time needed to launch and execute high-impact clinical trials. These CRO services are the outcome of a collaboration between Be The Match BioTherapies and CIBMTR, resulting in expertise and access to ...

Read More
news image

PROVENTION BIO AND VACTECH ANNOUNCE PUBLICATION OF PROOF-OF-CONCEPT DATA FOR COXSACKIEVIRUS B VACCINE

Provention Bio, Inc. | May 19, 2020

The preclinical prototype vaccine is well-tolerated and provides strong protection against coxsackievirus B infections and diabetes in relevant animal models. Results provide a solid scientific basis for human trials with Provention's PRV-101 vaccine. Read More

news image

Diagnostics

OXFORD BIOTHERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH IMMUNOGEN TO DEVELOP NOVEL ANTIBODY-DRUG CONJUGATES

Oxford BioTherapeutics | June 14, 2022

Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced a multi-year collaboration to research, develop and commercialize novel, first-in-class ADCs with ImmunoGen (IMGN), a leader in the expanding field of ADCs for the treatment of cancer. The companies will utilize ImmunoGen's linker-payload technology directed to novel targets identified via OBT's proprietary OGAP® discove...

Read More
news image

Industrial Impact

ADM FURTHER EXPANDS MICROBIAL SCIENCE AND TECHNOLOGY INNOVATION CAPABILITIES WITH INVESTMENT IN PRECISION FERMENTATION LEADER ACIES BIO

ADM | October 22, 2021

ADM a global leader in nutrition and agricultural origination and processing, annoThis investment will help ADM more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio’s extensive microbial capabilities and contract manufacturing services. “Microbial technology is unlocking disruptive opportunities in sustainable agriculture, sustainable materials and fuels, and alternative proteins, We’re prope...

Read More
news image

Cell and Gene Therapy, Medical

BE THE MATCH BIOTHERAPIES® INTRODUCES CIBMTR® CRO SERVICES

Be The Match BioTherapies® | January 18, 2023

On January 17, 2023, Be The Match BioTherapies, a company that provides solutions for organizations that develop and commercialize cell and gene therapies, introduced its offering of CIBMTR® clinical research organization services (CRO services), which significantly reduces the time needed to launch and execute high-impact clinical trials. These CRO services are the outcome of a collaboration between Be The Match BioTherapies and CIBMTR, resulting in expertise and access to ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us